Cargando…
Evidence-Based Guidelines for SARS-COV-2 Vaccination of Patients of Skin Allergic Diseases and Patients on Immuno-Therapeutics
There is a dearth of data regarding the safety and timing of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination of patients on immunosuppressive or immunomodulatory therapies. However, data from other vaccine trials may be extrapolated to get an idea regarding the recommend...
Autores principales: | Das, Anupam, De, Abhishek, Godse, Kiran, Sangolli, Prabhakar, Zawar, Vijay, Sharma, Nidhi, Girdhar, Mukesh, Podder, Indrashis, Shah, Bela, Dhar, Sandipan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644747/ https://www.ncbi.nlm.nih.gov/pubmed/36386095 http://dx.doi.org/10.4103/ijd.ijd_440_21 |
Ejemplares similares
-
Diagnosis and Management of Urticaria in Indian Settings: Skin Allergy Research Society's Guideline-2022
por: Godse, Kiran, et al.
Publicado: (2022) -
Use of Bleach Baths for Atopic Dermatitis: An Indian Perspective
por: Sharma, Nidhi, et al.
Publicado: (2022) -
Guidelines on Management of Atopic Dermatitis in India: An Evidence-Based Review and an Expert Consensus
por: Rajagopalan, Murlidhar, et al.
Publicado: (2019) -
CONSENSUS STATEMENT ON THE MANAGEMENT OF URTICARIA
por: Godse, Kiran V, et al.
Publicado: (2011) -
Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update
por: Godse, Kiran, et al.
Publicado: (2018)